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Exposure therapy induces extinction learning and is an effective treatment for specific
phobias. Sleep after learning promotes extinction memory and benefits therapy
success. As sleep-dependent memory-enhancing effects are based on memory
reactivations during sleep, here we aimed at applying the beneficial effect of sleep
on therapy success by cueing memories of subjective therapy success during non-
rapid eye movement sleep after in vivo exposure-based group therapy for spider
phobia. In addition, oscillatory correlates of re-presentation during sleep (i.e., sleep
spindles and slow oscillations) were investigated. After exposure therapy, spider-phobic
patients verbalized their subjectively experienced therapy success under presence of a
contextual odor. Then, patients napped for 90 min recorded by polysomnography. Half
of the sleep group received the odor during sleep while the other half was presented an
odorless vehicle as control. A third group served as a wake control group without odor
presentation. While exposure therapy significantly reduced spider-phobic symptoms
in all subjects, these symptoms could not be further reduced by re-presenting the
odor associated with therapy success, probably due to a ceiling effect of the highly
effective exposure therapy. However, odor re-exposure during sleep increased left-
lateralized frontal slow spindle (11.0–13.0 Hz) and right-lateralized parietal fast spindle
(13.0–15.0 Hz) activity, suggesting the possibility of a successful re-presentation of
therapy-related memories during sleep. Future studies need to further examine the
possibility to enhance therapy success by targeted memory reactivation (TMR) during
sleep.
Keywords: sleep, sleep spindles, targeted memory reactivation, extinction, spider phobia, arachnophobia, fear,
learning
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INTRODUCTION
Specific phobias are a form of anxiety disorder with an estimated
lifetime prevalence of 11.3% in the American population (Magee
et al., 1996). To date, exposure therapy is the most effective
treatment for anxiety disorders (Chambless and Ollendick,
2001), especially for the fear of spiders (Öst et al., 1997b). In
this approach, patients acquire a corrective experience in the
phobic situation which creates a new memory trace associated
with fear extinction (Bouton et al., 2006). Consolidation of
this newly learned extinction memory and its integration into
existing knowledge determines the reduction of symptoms which
is not always given: sometimes no response to the treatment, only
partial remission or relapse have been observed (Mystkowski
et al., 2002, 2006).
Sleep is a promising candidate to enhance treatment
outcome because of its well-known beneficial role in memory
consolidation (Rasch and Born, 2013). Recognizing the high
potential of sleep for the consolidation of newly acquired
extinction memory in a clinical setting, studies already examined
the role of sleep in fear extinction. In sensu exposure of spider-
phobic patients by video or virtual reality treatment led to
increased post-sleep fear consolidation and generalization (Pace-
Schott et al., 2012) and to a higher reduction of subjective fear
during approaching a spider (Kleim et al., 2014). The decrease in
fear of spiders was correlated with the percentage of sleep spent
in non-rapid eye movement (NREM) sleep stage 2 (Kleim et al.,
2014). Additionally, NREM sleep has also been shown to play
an active role in fear extinction in healthy participants (Hauner
et al., 2013).
On a neural basis, spontaneous reactivations of previously
learned, hippocampus-dependent information during NREM
sleep are suggested as the underlying mechanism behind the
memory-enhancing effect of sleep (Wilson and McNaughton,
1994). These spontaneous memory reactivations have been
successfully biased in humans. For example, associating a visuo-
spatial memory task with an odor and re-presenting the same
odor during slow-wave sleep (SWS) leads to a better post-
sleep memory performance compared with the presentation
of an odorless vehicle (Rasch et al., 2007; Rihm et al., 2014).
Furthermore, targeted memory reactivation (TMR) with the
same odor during SWS leads to congruent odor-specific changes
in electroencephalograph (EEG) activity: namely, increases in
frontal delta and parietal fast spindle activity, compared with
another, novel odor or an odorless vehicle (Rihm et al., 2014).
However, it is still unknown whether TMR during sleep can
be applied to a clinical setting to reactivate extinction memory
as indicated by oscillatory changes during sleep and thereby
enhance therapy success.
To test this question, spider-phobic patients underwent
in vivo exposure-based group therapy and verbalized their
subjective therapy success under the presence of a background
odor. Thereafter, patients stayed awake or napped with
re-presentation of the odor or presentation of an odorless
vehicle. Extinction memory was tested by changes in subjective
fear of spiders. We hypothesized on the behavioral level that
re-presentation of the odor during sleep will lead to more
pronounced extinction memory consolidation indicated by less
phobia-related fear compared with an odorless vehicle or a
wake interval without intervention. Additionally, we expected
that odor re-presentation during sleep will result in increased




Sixty medication-free spider-phobic volunteers participated
in this study and were randomly assigned to the three
groups: ‘‘wake without odor re-presentation’’, ‘‘sleep with odor
re-presentation’’, and ‘‘sleep with odorless vehicle presentation’’.
Diagnosis of spider phobia was based on the DSM-IV (American
Psychiatric Association, 2000) and assessed by the DIA-X
screening questionnaires (Wittchen and Pfister, 1997; Essau
et al., 1999). Exclusion criteria were general anxiety disorder,
depression, mental disorders (with the exception of specific
phobia), sleep-related disorders, medication intake up to
1 month prior to the experiment, major sleep disturbances
or sleep rhythm changes (night shifts, shift working, time
zone changes) during 8 weeks prior to the experiment,
previous experience with exposure therapy, fear of moths,
bad sleeping quality, and non-normal olfactory functions. In
detail, exclusion criteria were determined and tested as follows:
general anxiety disorder and depression were excluded via
DIA-X screening questionnaires. Additionally, the likelihood of
depression measured by the Beck’s depression inventory (Beck
et al., 1961) did not differ between groups (F(2,51) = 0.74,
p > 0.40). Bad sleeping quality was assessed by the pittsburgh
sleep quality index (PSQI; Buysse et al., 1989). Groups did not
differ in PSQI values (F(2,51) = 2.33, p > 0.14). Normal olfactory
function was ensured by excluding any nasal infections at the day
of the experiment, and by testing general olfactory performance
using the ‘‘Sniffin’ Sticks’’ inventory (Burghart, Germany). One
person of the odor re-presentation group had to be excluded
from this general olfactory performance analysis because of
missing data. The general ability to distinguish between 12
odors (mean: 11.49 ± 0.12) was comparable between groups
(F(2,50) = 0.86, p > 0.40). Additionally, subjective ratings on
general olfactory ability from 1 (very poor) to 5 (very good) were
also similar between groups (F(2,51) = 0.03, p > 0.90). All other
exclusion criteria were assessed by self-report.
Written informed consent was obtained after explaining the
procedure. The study was approved by the ethics committee of
the Faculty of Arts of the University of Zurich and in accordance
with the principles of the Declaration of Helsinki (Rickham,
1964). After the first therapy session, patients were randomly
assigned to three groups which differed regarding to the activity
after the first therapy session. On experimental days, participants
were instructed to get up at 7.00 a.m., not to take any naps and
not to ingest alcohol or caffeine containing drinks.
Six participants had to be excluded from the final sample
because of the following reasons: four participants showed
a decrease in the behavioral approach test (BAT) of more
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than 3 standard deviations (SD) between two subsequent
measure time points. Because of baseline differences between
the three groups in the BAT, we excluded two more
participants to match baselines. Furthermore, one participant
was transferred from the sleep group to the wake group
because her sleep time in N2 sleep was less than 5 min.
Thus, our final sample consisted of 54 patients (48 female,
6 male; mean age: 25.67 ± 6.80 years (SD); range: 18–45)
in the three groups: ‘‘wake without odor re-presentation
group’’ (N = 18), ‘‘sleep with odor re-presentation group’’
(N = 18), and ‘‘sleep with odorless vehicle presentation group’’
(N = 18).
Design and Procedure
The study consisted of two main phases: (i) pretreatment
screening via e-mail and phone; and (ii) treatment with two
exposure-based group therapy sessions separated by 1 week.
Before and after the two therapy sessions and after sleep or wake
interventions, we assessed the fear of spiders by subjective arousal
ratings and skin conductance responses (SCRs) during a picture
task with spiders andmoths, the distance patients could approach
a living spider, questionnaires, and saliva cortisol (Figure 1).
Exposure therapy consisted of two sessions separated by
1 week and was conducted in groups of 3–4 patients by
a trained psychotherapist. The exposure-based group therapy
manual was adapted from the treatment manual published
by Soravia et al. (2014). The first hour of both therapy
sessions involved psychoeducation about spider phobia and
its treatment with exposure therapy, fear circuits, avoidance
behavior, and group rules. After a 5-min break, 1 h of
exposure to a real spider followed. The exposures of the
first session included looking at the spider in a wine glass
and touching the spider in the glass with a pen. In the
second therapy session, patients additionally touched the
spider in the glass with a finger, caught the spider with
a glass, and let the spider walk over their hand. Patients
absolved each exposure under the direct guidance of the
psychotherapist.
Both sessions took place between 2 p.m. and 4 p.m. and
ended with a positive feedback round in which every patient
reported their personal success and experienced self-efficacy
during the therapy session. After the first session, subjectively
experienced therapy success was associated with an odor. Then,
polysomnography (PSG) was applied to patients in the sleep
group, and they could nap for 90 min, whereas patients in the
wake group stayed awake during this time. During stable NREM
sleep stages 2 and 3, half of the sleep group was re-presented the
odor of the feedback round while the other half was presented
the odorless vehicle. Wake patients were free to pursue activities
of their choice, but they were instructed not to take any naps
or longer rests, controlled by interviews and self-reports after
they returned to the lab. Analysis of the reports revealed that
wake patients used the 90-min interval to go for a walk, read,
do shopping, or have a tea in a nearby restaurant. Three
months after the second appointment, we sent the questionnaires
assessing spider phobia to all patients to measure possible time-
dependent effects of the intervention interval after the first
therapy session. Patients could return these questionnaires on a
voluntary basis.
Odor Delivery and Substance
The odor (magnolia and cherry blossom fragrance; Air Wick,
Slough, UK) was presented during the positive feedback round
at the end of therapy session 1 with the aim to associate the
odor with feelings of therapy success and self-efficacy. The odor
was sprayed into the room before the positive feedback round
and participants smelled it during evaluating their achievements
of the therapy. We chose a commercially available air freshener
as odor distributor because we wanted to ensure that all the
participants smelled the odor at the same time, which was not
realizable with our olfactometer.
The odor was also diluted in odorless mineral oil (1:300;
1,2-propanediol; Sigma-Aldrich, Munich, Germany) in order to
enable us to deliver it via an olfactometer. Since the odor was
never used in previous studies we conducted pilot studies to
ensure that the odor was clearly perceivable but not pungent
in the used dilution. It was presented again for 30 s during
sleep to the odor re-presentation group. The odorless vehicle
(1,2-propanediol; Sigma-Aldrich, Munich, Germany) served as
control stimulus in the vehicle presentation group, which means
that it was presented the same way as the odor in the control
group. Thirty seconds odor on-periods of odor presentations
(in the odor presentation group), or vehicle presentations (in
the vehicle presentation group), alternated with 30 s off-periods,
FIGURE 1 | Procedure. Patients came to two therapy sessions separated by 1 week. At the end of the first therapy session, verbalized subjective therapy success
was associated with an odor. Thereafter, patients slept or stayed awake. For the sleep groups, we presented the odor or an odorless vehicle during non-rapid eye
movement (NREM) sleep. Fear was measured at five different time points: as baseline before the first exposure therapy (T1), after the first exposure therapy session
(T2), after the sleep or wake interval (T3), before the second exposure therapy (T4), and after it (T5).
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during which room air was presented. The odor and the
vehicle were delivered via a 12-channel computer-controlled
olfactometer designed after Lorig (2000). Room air was filtered
before entering the system, and airflow was held constant at
3 l/min. To avoid tactile or thermal shifts associated with odor
onset, half of the air stream was presented continuously to the
subject, and only the other half was switched between room
air and vehicle or odor by computer-controlled valves. The
olfactometer was placed in a separate room (adjacent to the
subject’s sleeping room) and was connected to the subject’s mask
via Teflon tubes, which allowed regulating the odor stimulation
without disturbing the subject. The subject received the odor
via a small nasal mask, which ensured constant stimulation but
permitted normal breathing. We presented the odor or vehicle as
soon as we detected stable N2 sleep with visible K-complexes for
2 min. Presentations continued when participants transited into
N3, but were stopped immediately whenever we saw the slightest
signs of arousal or rapid eye movement (REM) sleep.
Assessment of Fear of Spiders
Fear of spiders was measured at five different time points: before
(T1) and after (T2) the first therapy, after sleep or wakefulness
(T3), and before (T4) and after (T5) the second therapy. Fear
measures were the subjective arousal ratings and SCRs in a
computer-based picture task with spider pictures, the distance
to which patients could approach a living spider, subjective fear
during approaching, and questionnaires about the fear of spiders.
Additionally, saliva cortisol, general reaction times (RTs) and
response accuracy were assessed at each time point.
Picture Task
In the computer-based picture task participants rated their
arousal to 15 pictures of spiders and 15 pictures of moths
which served as neutral control pictures (Hauner et al., 2012).
Additionally, their SCRs to the pictures were recorded. To avoid
habituation, five different sets of moth and spider pictures were
created containing pictures that were matched with regard to
size and color of the animals and background color intensity.
The sets were presented in a pseudo-randomized order, whereas
the 30 pictures in the set were presented randomly. After the
presentation of a cross-hair for 1 s, pictures of each set were
presented for 7 s with a randomized inter-stimulus interval (ISI)
of 7–8 s. Participants were instructed to look at the pictures as
long as possible, but if the picture became unbearable to them,
they could press a key to make it disappear. After watching a
picture, participants rated their arousal on a scale from 1 (very
calm) to 7 (very aroused). The difference between arousal to
spider and moth pictures and if participants could look at the
spider pictures for the whole 7 s without skipping them were
taken as fear measurements.
BAT and VAS
After completing the picture task, the BAT was conducted.
During this task, participants had to approach a living spider
in a closed box until the arousal was as high as possible but
still bearable. Thus, the BAT score expresses the avoidance level
towards the feared object.
Participants were accompanied to the room in which the
spider was placed and had time to approach the spider slowly
and at their own speed. When participants could not approach
further, distance to the box that contained the spider was
measured. If participants were unable to enter the room because
their fear was too strong, distance to the door (600 cm) was taken
as distance value.
After the BAT, the subjectively experienced anxiety during
approaching the spider was rated on visual analog scales (VAS)
concerning questions about the intensity of the momentary fear,
the momentary feeling of physical tension, the need to leave the
situation and the most catastrophic spider-related cognition by
marking a cross along the 10 cm horizontal line of the scale.
One participant of the odorless vehicle presentation group was
excluded from the analyses of VAS data because of missing
baseline data.
Spider Phobia Questionnaire (SPQ) and Fear of
Spiders Questionnaire (FSQ)
Spider phobia at the five different time points was also
assessed by German versions of the Spider Phobia Questionnaire
(SPQ; Watts and Sharrock, 1984) and the Fear of Spiders
Questionnaire (FSQ; Szymanski and O’Donohue, 1995). These
two questionnaires were also sent to participants 3 months after
the second session of the exposure therapy to assess possible
time dependent changes in spider-related fear. One subject of
the wake group had to be excluded from the analyses because of
missing baseline data, resulting in 53 subjects for SPQ and FSQ
values. Concerning the follow up, 30 out of these 53 participants
sent the questionnaires back (re-presentation of odor: N = 11,
presentation of odorless vehicle: N = 8, wake: N = 11).
SCRs
SCRs were recorded with Brain Vision Recorder (Munich,
Germany). Data was collected from the non-dominant hand with
Ag/AgCl electrodes filled with electrodermal electrode paste.
Data was sampled at 250 Hz. To avoid movement artifacts,
participants were instructed not to move during the whole task
and the dominant hand was placed on the key with which the
picture could be skipped. Before analysis, visually inspected,
artifact-free data was preprocessed with MATLAB (MATLAB
R2011a) by using high pass and low pass filters of 0.5 and
1.5 Hz respectively, applying a logarithmic transformation to
control for the left-skewed distribution of SCR amplitudes,
and by subtracting a baseline of 1 s prior to stimulus onset.
Minimal and maximal points of responses were automatically
detected during the presentation of the pictures, i.e., within
the time frame of 1–7 s after stimulus onset. Amplitudes were
calculated by subtracting the minimal from the maximal values.
Finally, a range correction was performed to account for large
inter-individual differences in electrodermal reactivity (Lykken
et al., 1966; Boucsein et al., 2012). Pictures that were skipped
by participants after their onset were treated equally to the
other stimuli if no artifacts were scored by visual inspection
and this SCR data was also considered between 1 and 7 s
after picture onset. This was necessary because of the different
picture presentation lengths depending on the time point when
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participants skipped the pictures. A uniform analysis would not
have been possible for the mere picture presentation times, and
we would have had to exclude these trials.Three participants had
to be excluded from the analysis (re-presentation of odorless
vehicle:N = 2, wake:N = 1) because ofmissing skin conductance
data at T3.
Cortisol, General Reaction Times and Accuracy
To ensure that participants did not differ in their general state of
wakefulness and vigilance, or stress, they underwent a RT and
response accuracy test and gave saliva samples at all five fear
measure time points T1–T5.
Cortisol samples were collected using Salivette collection
tubes (Sarstedt, Germany) and stored at −20◦C until analysis by
the biochemical laboratory at the Institute of Psychology of the
University of Zurich.
RTs were assessed by pressing a key as fast as possible
whenever a big red disk appeared on a computer screen (Little
et al., 1998). In 40 trials, the subjects fixed their gaze on a cross,
displayed for 500–1000 ms on a white screen. In 35 trials a red
disk appeared while the screen remained white in five random
no-go trials. Response accuracy was calculated as the possibility
to inhibit the key press to the five no-go trials.
Sleep and EEG Recordings
Sleep was recorded by standard PSGwith a 128-channel electrode
cap (Geodesic, USA). Data was sampled at 500 Hz. For sleep
scoring, EEG data was reduced to six scalp electrodes (F3, F4, C3,
C4, P3, and P4; according to the International 10–20 System),
re-referenced to contralateral mastoid electrodes, and filtered
between 0.3 and 30 Hz (Iber et al., 2007). In addition to the
online identification of sleep stages, EEG was scored offline
by two experienced lab members according to the American
Association of Sleep Medicine scoring manual (Iber et al., 2007).
Sleep stages scored were wake after sleep onset (WASO), NREM
sleep stages N1, N2, N3, REM sleep, and movement. For a more
fine-grained exploratory analysis of effects of odor cueing during
sleep, EEG recordings were subjected to spectral analyses, spindle
analysis and arousal control analyses using Brain Vision Analyzer
2 (Brain Products, Germany).
Spectral Power Analysis
Data of the 30 s on- and off-periods of odor and vehicle
stimulation were separated each into three blocks of artifact-
free EEG including 10 s of data with an overlap of 10% between
blocks. AHanning windowwas applied on each data block before
calculating power spectra using fast fourier transformation
(FFT) with a resolution of 0.2 Hz. Individual mean power in
the following EEG bands was determined: frontal slow delta
(0.5–1.5 Hz), frontal delta (1.5–4.5 Hz), frontal slow spindle
(11.0–13.0 Hz) and parietal fast spindle (13.0–15.0 Hz) bands.
Data was exported as absolute power spectra. Power values
were extracted from left and right frontal and parietal electrode
clusters (as described in the Supplementary Material of Cordi
et al., 2014). In order to take individual differences into account,
the data was first normalized with an average power band
between 0.5 and 50 Hz. Then, the blocks of odor on- and off-
periods were used to calculate the percent change of spectral
power such that power during the first 10 s interval of the odor
on-period was expressed as percentage of the power during the
last 10 s interval of the preceding odor off-period (set to 100%).
Possible differences between hemispheres were considered by
analyzing the left and the right hemisphere separately. Four
participants in the sleep groups had to be excluded from the
power analysis because they had fragmented NREM sleep during
their nap and ended up having only one or less than one re-
presentations. Nevertheless, their total sleep time and their sleep
time spent in N2 sleep (>10 min) was too long to transfer them
post hoc to the wake group. This resulted in 32 participants
for the EEG analysis (N = 16 in the sleep with odor re-
presentation group;N = 16 in the sleep with vehicle presentation
group).
Spindle Analysis
For the Spindle Analysis, movement artifact-free data of the
10 s on- and off-periods after and before the odor or vehicle
presentations were used. Discrete slow (11.0–12.9 Hz) and fast
(13.0–14.9 Hz) spindles were identified and averaged over left
and right frontal (F3 and F4) and parietal (P3 and P4) EEG
recording sites (Schimicek et al., 1994; Gais et al., 2002). In
brief, power was extracted in the frequency bands of interest
(11.0–12.9 Hz; 13.0–14.9 Hz), and events for which the power
signal exceeded a fixed amplitude threshold (±10 µV) for
0.5–3 s were counted as spindles. Movement artifact-free 10-s
segments after and before odor presentation were analyzed
separately for each channel (maximal difference in EMG activity
of <200 µV). Data was exported and spindle counts and
density were calculated in SPSS (IBM, NY, USA). We calculated
spindle counts as the sum of the number of spindles in the
10-s on-periods after odor or vehicle onset relativized with the
sum of the number of spindles in the 10-s off intervals. Thus,
we obtained a change in percent in the number of spindles
before compared with after the odor or vehicle presentation
onset. To calculate spindle density, spindle counts for the
on- and off-periods were divided by the number of analyzed
10-s epochs and the values for the on-periods were relativized
with the values for the off-periods, also resulting a change in
percent from before compared with during the odor or vehicle
presentation. Two participants (one in the sleep with odor re-
presentation, one in the odorless vehicle presentation group)
had to be excluded from this spindle analysis because EMG
electrodes fell off during the nap and the EMG criterion was
not applicable. We had to exclude three more participants (two
in the sleep with odor re-presentation, one in the odorless
vehicle presentation group) for the spindle analysis over parietal
electrodes because they had no spindles at all in the analyzed
off-segments. Therefore, a calculation of the count and density
values by division of the on- by the off-values was not
possible.
EEG Arousal Control
To control for possible arousals in response to odor
presentations, we visually scored the arousals in the EEG
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data during 10 s after the odor onset. We used the arousal
scoring rules of the American Sleep Disorders Association
(Bonnet et al., 1992). According to these rules, arousals were
scored when EEG data shifted for at least 3 s to a higher
frequency (theta, alpha, and/or>16 Hz) in NREM sleep.
Statistical Analysis
EEG data was analyzed by repeated measures analysis
of variances (ANOVAs) with repetition in the factor
‘‘lateralization’’ (left vs. right hemisphere) between sleep
groups (odor re-presentation vs. odorless vehicle presentation).
Significant interactions were further analyzed by post hoc t-tests
between the two groups.
For behavioral data analyses, we proceeded similar as Kleim
et al. (2014). We focused on the differences between groups
between T2 and T3 (immediately after the first therapy and
after the sleep or wake interval) and between T3 and T4 (after
the sleep or wake interval at the end of the first session and
before the second session 1 week later) separately by calculating
absolute and relative values. Therefore, we subtracted data at
T2 from T3, and at T3 from T4. For relative changes, data
of T3 was divided by T1 and multiplied by 100. Similarly for
the second session, for relative values data of T4 was divided
by T3 and multiplied by 100. Calculation of relative changes
was not possible for the BAT distance scores as most patients
reached a distance of 0 cm at T3. These absolute and relative
values were compared by one-way ANOVAs between the three
groups.
In order to show the general impact of extinction learning
on fear of spiders, we focused only on the therapy sessions
and analyzed data by using a 2 × 2 × 3 ANOVA with the
repeated measures factors session (first vs. second session) and
time (pre vs. post therapy) between groups (odor re-presentation
during sleep vs. vehicle presentation during sleep vs. wake).
Additionally, chi square tests were conducted to analyze if groups
differed in skipping spider pictures at T3 and T4. A p value< 0.05
two-tailed was considered significant.
RESULTS
Fear of Spiders
In general, exposure therapy was highly efficient and significantly
reduced the subjects’ fear of spiders as measured by approach
behavior (BAT), subjective fear ratings (VAS), spider phobia
questionnaires (SPQ, FSQ), electrodermal activity (SCRs),
and subjective arousal during exposure to spider pictures.
In particular, we found a main effect of time (before and
after the therapy; all p < 0.001) and session (first and
second therapy; all p < 0.001) as well as significant time
by session interactions (all p ≤ 0.02; except for FSQ:
p = 0.08) for all of these measures. These effects indicated
a decrease in fear after the therapy sessions compared with
before the sessions, and a decrease in fear from the first
to the second session. The interaction reflected a stronger
reduction of fear during the first than during the second
session.
Despite the great efficacy of our therapy concerning symptom
reduction in general in all three groups, we observed no
evidence that odor re-presentation during sleep or sleep in
general improved therapy success compared with the wake
control. The results of these parameters are listed below. A
Bonferroni-corrected bivariate correlation analysis between each
relative and absolute behavioral parameter and the number
of reactivations in the odor re-presentation group did not
reveal any significant results (all r between −0.55 and 0.40, all
p > 0.05).
BAT and VAS
The ability to approach a living spider was not influenced
by sleep or odor re-presentation during sleep compared with
wake (F(2,51) = 0.48, p > 0.60), and differences between
the intervention groups were also not visible 1 week later
(F(2,51) = 0.26, p > 0.70; Figure 2A). There were also no
differences between groups when analyzing the differential
changes between each of the succeeding pairs of measure time
points (all p > 0.50; Table 1). Absolute and relative VAS ratings
in all four scales did also not differ between the three groups at
T3 (all p > 0.20) or at T4 1 week later (all p > 0.40; Figure 2B).
Picture Task
Similarly, the difference in subjective arousal towards phobic and
non-phobic pictures was the same for the three groups at T3
(F(2,51) = 0.42, p > 0.60), and 1 week later at T4 (F(2,51) = 2.21,
p = 0.12). Groups did also not differ in the duration of looking
at the spider pictures at T3 (χ2(2,52) = 1.04, p > 0.50) or T4
(χ2(2,52) = 1.66, p > 0.40; Figure 2C).
SPQ and FSQ
None of the questionnaires revealed differences between the
three groups at T3 (all p > 0.15) or T4 (all p > 0.70) in absolute or
relative values (Figures 2D,E). Three months after the therapy,
the three groups did still not differ in their absolute or relative
values in FSQ and SPQ scores compared with the baseline before
the first (all p > 0.17) or after the second therapy session (all
p > 0.30).
SCRs
At every time point T1–T4, patients revealed higher physiological
reactivity to spider compared with moth pictures, independent of
group (all p < 0.005). However, after the second therapy at T5,
the SCRs to spiders and moths were comparable (F(2,48) = 1.49,
p > 0.20). The SCRs of the three groups were comparable at all
time points (all p > 0.12).
Cortisol, General RT and Accuracy
The three groups did not differ in absolute nor in relative changes
in cortisol values at T3 (both p > 0.20) or T4 (both p > 0.40).
The three groups did also not differ in general RT or response
accuracy after sleep or wakefulness at T3 (both p > 0.70), nor at
T4 (both p > 0.40).
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FIGURE 2 | Absolute changes in fear parameters from time point T2 (after the first exposure therapy) to T3 (after sleep/wake) and from T3 (after
sleep/wake) to T4 (1 week later), for the following measures: (A) behavioral approach test (BAT), (B) fear during BAT measured by four different visual
analog scales (VAS) for momentary fear (fear), momentary feeling of physical tension (tension), need to leave the situation (flight) and catastrophic
spider-related cognitions (catastrophe), (C) the differences in subjective arousal between moth and spider pictures, (D) scores for the spider phobia
questionnaire (SPQ), and (E) scores for the fear of spiders questionnaire (FSQ). Negative values indicate a decrease in fear compared with the time point
before. Data are Mean ± SEM.
Sleep and Re-Presentation of Therapy
Success
Sleep Architecture
Neither total sleep time nor percentage of WASO, N1,
N2, N3, and movement nor number of olfactory stimuli
presentations differed between the two sleep groups (all
p > 0.14; Table 2). All odor re-presentations during sleep
were placed in sleep stages N2 or N3 (100% correct
placement for every patient in both groups). The number
of re-presentations ranged from 12–65 in the odor
presentation and from 6–59 in the vehicle presentation
group. Only 10 out of 36 patients reached REM sleep (odor
re-presentation: N = 4; vehicle presentation: N = 6). Their
percentage in REM sleep did also not differ (χ2(1,9) = 10.00,
p > 0.30).
Effects of Cued Odor Presentations on Oscillatory
Activity
In line with our hypothesis, EEG activity in the spindle bands
during the first 10 s of odor re-presentation in NREM sleep
induced by the same odor presented at the end of extinction
learning differed from EEG activity during presenting an
odorless vehicle.
Over the right parietal hemisphere, the interaction between
group and laterality was highly significant (F(1,30) = 10.93,
p = 0.002) for relative changes in fast spindle activity
(13.0–15.0 Hz) from odor off- to odor on-periods. Moreover,
these changes were higher in the odor re-presentation
group (106.86 ± 6.05%) compared with the vehicle group
(89.27 ± 6.05%, t(30) = 2.06, p = 0.049). No difference
occurred in the left parietal hemisphere (odor re-presentation:
Frontiers in Human Neuroscience | www.frontiersin.org 7 June 2016 | Volume 10 | Article 340
Rihm et al. Therapy Re-presentation during NREM Sleep
TABLE 1 | Baseline values and differential changes in distance in cm
during the behavioral approach test (BAT) between each pair of
succeeding time points T1 (beginning of the first session), T2 (after the
first exposure therapy), T3 (after the sleep/wake interval), T4 (1 week later,
beginning of second session) and T5 (after the second exposure therapy)
and for the decrease between the two therapy sessions.
Time Odor Odorless Wake F(2,51) p
point (N = 18) vehicle (N = 18) (N = 18)
T1 123.56 ± 26.80 119.17 ± 32.45 93.17 ± 18.05 0.39 0.68
T2-T1 −90.22 ± 24.13 −87.01 ± 23.74 −59.78 ± 14.84 0.62 0.54
T3-T2 −8.28 ± 8.04 −1.00 ± 6.03 −8.50 ± 3.66 0.48 0.62
T4-T3 10.28 ± 11.71 20.00 ± 12.02 20.28 ± 9.51 0.26 0.77
T5-T4 −29.83 ± 7.86 −30.94 ± 15.69 −33.44 ± 42.14 0.03 0.98
T5-T2 −27.83 ± 6.92 −11.94 ± 11.55 −21.67 ± 27.12 0.87 0.43
Negative values indicate a closer approach to the spider compared with the time
point before. Data are Means ± SEM. Right columns indicate F and p values for
one-way ANOVAs.
100.35 ± 5.84% vs. vehicle presentation: 91.02 ± 5.84%;
t(30) = 1.13, p > 0.2; Figures 3, 4). The differences in relative fast
spindle power changes were also significantly pronounced over
non-lateralized frontal sites, as revealed by a scalp distribution
(Figure 4). There was no overall difference between the two sleep
groups (p= 0.11).
Interestingly, a lateralization was also observed in the
slow spindle band (11.0–13 Hz). Again, the interaction
between odor re-presentation group and laterality was
significant (F(1,30) = 6.65, p = 0.02). Patients with odor
re-presentation during sleep revealed higher changes in
slow spindle activity over the left frontal hemisphere
(115.18 ± 6.80%) compared with the odorless vehicle
group (94.87 ± 6.80%, t(30) = 2.11, p = 0.04). No
difference occurred over the right frontal hemisphere
(odor re-presentation: 104.05 ± 5.71% vs. vehicle
presentation: 99.25 ± 5.71%, t(30) = 0.59, p > 0.50;
Figures 3, 4).
TABLE 2 | Wake after sleep onset (WASO), non-rapid eye movement
(NREM) sleep stages 1 (N1) and 2 (N2), slow-wave sleep (SWS) (N3), and
rapid eye movement (REM) sleep in % of total sleep time (total time).
Sleep Odor Odorless vehicle t(34) p
parameters (N = 18) (N = 18)
WASO (%) 11.41 ± 2.55 18.92 ± 4.37 1.49 0.15
N1 (%) 15.26 ± 1.76 12.59 ± 1.72 −1.08 0.29
N2 (%) 47.26 ± 4.70 41.52 ± 3.60 −0.97 0.34
N3 (%) 24.50 ± 5.66 23.22 ± 4.34 −0.18 0.86
REM (%) a 4.27 ± 0.66 8.97 ± 2.18 0.35
Movement (%) 0.63 ± 0.23 0.72 ± 0.25 0.24 0.81
Total time (min) 92.61 ± 7.03 84.50 ± 7.24 −0.80 0.43
Number stimulationsb 28.56 ± 3.69 35.56 ± 4.36 −1.23 0.23
aOnly 10 out of the 36 patients reached REM sleep (reactivation with odor: N = 4;
presentation of odorless vehicle: N = 6; df = 9; χ2 test). bTwo of the sleep
participants in each sleep group did not reach stable N2 sleep and therefore
only one or less than one reactivations. These participants are excluded from
the EEG analysis and from the number of reactivation statistics, resulting in 16
participants per group. Right columns indicate t and p values for t tests. Data are
Means ± SEM.
FIGURE 3 | Changes in relative electroencephalograph (EEG) activity
during the first 10 s of odor on-intervals compared with the last 10 s of
odor off-intervals. Data for slow delta (0.5–1.5 Hz), delta (1.5–4.5 Hz) and
slow spindle (11.0–13.0 Hz) activity are retrieved from frontal electrodes. Data
for fast spindle activity (13.0–15.0 Hz) are retrieved from parietal electrodes. L:
left hemisphere, R: right hemisphere. Data are Means ± SEM. p values from
one-way ANOVAs are indicated (∗p < 0.05, ∗∗p < 0.01).
The finding of increased spindle activity after odor
re-presentation was paralleled by distinct sleep spindles:
changes in fast parietal spindle counts were distinctly
enhanced in the odor re-presentation compared with the
odorless vehicle group, although no effect of lateralization was
observed (odor re-presentation: 172.84 ± 24.54% vs. vehicle
presentation: 95.33 ± 25.47%; F(1,25) = 4.80, p = 0.04). A
similar pattern was observed for changes in frontal slow spindle
counts (135.93 ± 8.44% vs. 98.67 ± 8.44%; F(1,28) = 9.74,
p = 0.004). Changes in spindle density were also higher
after odor presentation compared with odorless vehicle
presentation for frontal slow spindles (odor presentation:
108.74 ± 5.27%, odorless vehicle presentation: 91.66 ± 5.27%;
F(1,28) = 5.25, p = 0.03) and showed a statistical trend for
parietal fast spindles (odor re-presentation: 142.40 ± 21.18%,
odorless vehicle presentation: 88.31 ± 21.98%; F(1,25) = 3.14,
p = 0.09). In these analyses, neither a lateralization main
effect nor a lateralization by condition interaction was
found.
Contrary to the two spindle bands, we observed no effect
of odor re-presentation in frontal delta activity, neither as
interaction with laterality nor as main effect of group (both
p > 0.20; Figure 3). Independent of group, frontal delta activity
(1.5–4.5 Hz) over the left hemisphere (103.46 ± 2.53) was
significantly higher than over the right hemisphere (99.67± 2.60;
F(1,30) = 4.95, p = 0.03). Descriptively, the decrease was
higher in the odor re-presentation group (Figure 3). The
re-presentation had no impact on frontal slow delta power
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FIGURE 4 | Scalp distributions of the sleep odor and sleep vehicle groups. Figures illustrate the scalp distributions in the fast (13.00–15 Hz) and slow
(11.0–13.0 Hz) spindle bands and in the delta band (1.5–4.5 Hz). Data is indicated for the percentage change from the 10-s off interval to the 10-s on interval for the
sleep with odor re-presentation and the sleep with vehicle presentation groups. The last column illustrates the difference in scalp distributions between the two
groups. We conducted a t test for each electrode site between the two groups and marked electrodes in white in the difference plots if the p value was < 0.05.
(0.5–1.5 Hz, all p > 0.06). Importantly, odor presentation did
not result in changes in EEG arousals after odor onset compared
with odorless vehicle presentation (t(30) = 0, p = 1.0; odor
re-presentation: mean = 1.38 ± 0.30; vehicle presentation:
mean= 1.38± 0.30).
DISCUSSION
Our results show that re-presentation of an odor previously
cued with subjectively experienced therapy success during
NREM sleep did not result in differences in therapy outcome
between patients that were re-presented the odor, patients
that were re-presented an odorless vehicle, and patients that
did not sleep at all. However, we found that re-presenting
the previously cued odor during NREM sleep leads to
increased frontal slow and parietal fast spindle activity
compared with the presentation of an odorless vehicle.
But, contrary to our hypothesis, these changes in EEG
activity were not present in the delta band. Thus, our
findings indicate that re-presentation of an odor which was
previously associated with subjective therapy success is visible
in changes in electrophysiological spindle activity, but that
in vivo exposure group therapy might cause a ceiling effect
in extinction learning and thus extinction memory could
not be further improved by sleep or odor re-presentations
during sleep. Alternatively, cueing of the verbalized therapy
success could have been not potent enough to induce therapy
success.
In our previous work we could show that EEG activity
in response to TMR with a different odor than during
learning was comparable with odorless vehicle presentation
(Rihm et al., 2014). Therefore, we can assume that effects
on spindles in this study are due to the presentation of
the memory-associated cue rather than mere effects of sleep
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preservation in response to environmental stimuli and thus
we included only an odorless vehicle presentation group in
this study. However, please note that we could show this
effect only in healthy participants, and we can only speculate
that the spindle responses to non-cued odors are similar in
anxiety patients. Furthermore, previous studies support the
notion of a critical role of NREM sleep in fear extinction
(Hauner et al., 2013; Kleim et al., 2014). The finding that
TMR with the same odor presented during learning alters EEG
activity during NREM sleep is in line with this notion and
with our previous findings (Rihm et al., 2014), although in
the present study, this effect depended on lateralization. Our
results suggest that the neural mechanisms of fear extinction
consolidation during NREM sleep might be similar to those
of declarative memory consolidation, where thalamo-cortical
spindles during SWS sleep establish a dialog between the
hippocampus and neocortex, enabling information transfer
between these brain regions (Mölle and Born, 2011). The
asymmetry in terms of left lateralization for slow spindle
activity and right lateralization for parietal fast spindle activity
during olfactory TMR is a new finding. A possible explanation
for the lateralization is the strong emotional involvement
while verbalizing subjective therapy success. On the one hand,
increases of left-lateralized frontal EEG activity have been
associated with tasks that induce a good mood (Davidson
and Fox, 1982; Ekman and Davidson, 1993) and with greater
trait approach motivation (Coan and Allen, 2003; Amodio
et al., 2008). In our study, good mood, and a motivation to
approach the feared object exactly describe the patients’ state
after verbalizing subjective therapy success and associated self-
efficacy. On the other hand, right posterior regions have been
involved in the processing of emotional stimuli. For example,
both positive and negative ERP components to emotional stimuli
are larger over right parietal regions (Kayser et al., 1997;
Keil et al., 2001; Thomas et al., 2007). Importantly, we can
exclude arousals or awakenings in the reactivation group as a
possible explanation for the observed changes in spindle spectral
power.
The results of our study do not support the findings
of previous studies that sleep benefits the enhancement of
extinction memory on a behavioral level and thus reduces
fear after exposure. In contrast to our in vivo exposure-based
group therapy, these studies used in sensu therapy with a
virtual environment (Kleim et al., 2014) or a short movie clip
(Pace-Schott et al., 2012). A reason for the missing behavioral
effects of sleep on extinction memory consolidation after our
in vivo exposure therapy could be a possible ceiling effect of
extinction learning. Exposure therapy has been shown to be a
very effective treatment, even after one session (Öst, 1996; Öst
et al., 1997a,b) and in particular for spider phobia (Choy et al.,
2007; Soravia et al., 2014). Since we applied a well-established
experimental effect to a real psychotherapeutical situation in a
group format, it was not possible to create a highly controlled
experimental setting as for example in studies investigating the
effect of sleep on declarative memory, where it is common to
define a fixed learning criterion, e.g., 60% of the overall learning
material (Rasch et al., 2007; Rihm et al., 2014) or the placement
within a certain diameter from the target stimulus (Rudoy et al.,
2009).
Due to the absence of immediate effects of sleep on treatment
outcome after a virtual reality treatment (Kleim et al., 2014), we
measured fear again 1 week after the initial therapy. However, the
different sleep groups and the wake group did also not differ at
this time point, nor did they 3 months later. Importantly, we can
rule out different vigilance states between the groups, especially
after the sleep intervention, on behavioral results by comparing
RT tests and correct responses in a go–no go test at every time
point.
Since we applied a group therapy setting, it was not possible
to individually associate the extinction learning process with
the odor. Anxiety in the observing patients—beside the acting
patient—would eventually have led to the association of fear with
the odor. Moreover, after successful odor-extinction association,
other patient’s subsequent extinction trials with presentation
of the odor could have weakened the new memory trace,
since TMR on declarative memory during wakefulness led to a
destabilization of the newly acquired memory trace (Diekelmann
et al., 2011). However, we cannot rule out the possibility
that cueing only the verbalized therapy success—which is
rather abstract compared with specific actions during extinction
learning—could have been too weak to enhance extinction
memory. Taken together, re-exposure to in vivo exposure-
based group therapy for spider phobia during NREM sleep
leads to lateralized increases in slow and fast spindle bands.
This impact on the EEG could be reflected by reduced fear
of spiders, if exposure learning is not already at ceiling.
For future studies we suggest using other extinction learning
paradigms, e.g., in sensu, to further explore the present
finding.
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